Some isolates of
SHV-5 beta-lactamase-producing Klebsiella pneumoniae K2 from a single-strain outbreak of
cross-infection produced approximately five-fold more
beta-lactamase than others. We investigated three possible genetic mechanisms of this hyperproduction: the presence of a more powerful promoter, an increase in plasmid copy number or an amplification of the gene on a plasmid. No differences between low and high
beta-lactamase producers were detected in the promoter region of the
SHV-5 beta-lactamase gene, which closely resembled that of SHV-2.
SHV-5 beta-lactamase production was encoded on a low copy number plasmid, but
DNA-
DNA hybridization with an SHV-specific probe detected a higher gene dose in hyperproducers. The
beta-lactamase hyperproduction was unstable on repeated subculture, with a reduction of about 75% after 100 generations. Hyperproducing mutants of a low-producing Klebsiella and its Escherichia coli K-12 transconjugants could be selected in vitro at a frequency of 10(-5) to 10(-6) and these variants had an increased
SHV-5 beta-lactamase gene copy number on low copy number plasmids. We conclude that hyperproduction of the extended-spectrum
beta-lactamase was caused by gene amplification that could be easily lost or gained in vitro. Since the change to hyperproduction occurred at a high frequency and hyperproducers showed increased resistance to many
beta-lactams and
beta-lactam/
beta-lactamase inhibitor combinations, we suspect that these variants may readily be selected in patients during
antibiotic therapy.